Our latest news, insights & events
Herzog Fox & Neeman is delighted to have been ranked band 1 in 8 practice areas by Chambers Global 2019:
Chambers 2019 | Herzog Fox & Neeman Ranked Band-1 in 8 Practice Areas!
Herzog, Fox & Neeman acted for ParagonEx Ltd., a BVI company engaged in development and supply of software platforms and
Herzog Fox & Neeman Represents ParagonEx in Deal with BNN Technology and MICT Inc.
Meir Linzen, Herzog Fox & Neeman’s Managing Partner, and Gilad Majerowicz, Head of Herzog fox & Neeman’s Korea Practice, were
Meir Linzen and Gilad Majerowicz Discuss Innovation in Israel with Korea’s Chosun Ilbo
Herzog Fox & Neeman’s Head of Japan Practice and Commercial Partner, Gilad Majerowicz, discussed investing in Israeli Hi-Tech at November’s Cybertech Tokyo. Click here for more
Named by WirelessWire News of Japan as “the most interesting session in the Cybertech Tokyo conference this year ” | Gilad Majerowicz on Investments in Israel
Herzog Fox & Neeman represented Nazareth-based AlphaOmega, creators and manufacturers of brain-stimulation devices for surgery in a $7 million JV
Herzog Fox & Neeman Represents AlphaOmega in JV with GIBF
Herzog Fox & Neeman Partners Yair Geva, Tomer Farkash, Dan Sharot, and Ofer Granot, together with Associate Michal Shirin, represented Israeli biopharmaceutical company Entera Bio
Herzog Fox & Neeman Represents Entera Bio in $270m Amgen Licensing Deal
Herzog, Fox & Neeman acted for 888 US Inc., a wholly owned subsidiary of 888 Holdings Plc, in its acquisition
Herzog Fox & Neeman Represents 888 in Acquisition of AAPN from Avenue OLG Entertainment
Herzog Fox & Neeman represented CodeMonkey Studio Inc. in their acquisition by TAL Education Group. CodeMonkey’s specialty is game-like computer
Herzog Fox & Neeman Represents CodeMonkey Studio Inc. in Buy-Out
In a precedential ruling, a Delaware Court has allowed Fresenius to withdraw from a $4.75 billion acquisition of Acorn Pharmaceuticals
The Start-Up’s Worst Nightmare: Precedential US Ruling on Exits
Herzog Fox & Neeman advised Linse Capital in a $63 million investment in Hod HaSharon-based Valens. Linse was advised by Hanan
Herzog Fox & Neeman Advises Linse Capital Through Investment in Valens
In one of the biggest and most successful exits in Israeli tech history, cybersecurity start-up, Sygnia, founded in 2015 by


